Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction: Results From GISSI-3 Trial

Author： Franzosi M.G.   Maggioni A.P.   Santoro E.   Tognoni G.   Cavalieri E.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.3, 1998-03, pp. : 337-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction: Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial

By Franzosi M.G.  

PharmacoEconomics, Vol. 19, Iss. 4, 2001-04 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction: Economic Evaluation of the Acute Infarction Ramipril Efficacy (AIRE) Study for Germany from the Perspective of Statutory Health Insurance

By Schädlich P.K.  

PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. : 653-669

Adis International

Access to resources Recommend Favorite

Patients with acute myocardial infarction (MI) benefit from early treatment with statins

By  

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Pharmacology and clinical trial results of lanoteplase in acute myocardial infarction

By Llevadot J.   Giugliano R.P.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2689-2694

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction

By Moser M.   Bode C.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 329-335

Informa Healthcare

Access to resources Recommend Favorite